Tomatidine
Internal ID | 64e79450-996e-45ab-908e-cd0f95206ce6 |
Taxonomy | Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal alkaloids > Spirosolanes and derivatives |
IUPAC Name | (1R,2S,4S,5'S,6S,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-piperidine]-16-ol |
SMILES (Canonical) | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)O)C)C)C)NC1 |
SMILES (Isomeric) | C[C@H]1CC[C@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(CC[C@@H](C6)O)C)C)C)NC1 |
InChI | InChI=1S/C27H45NO2/c1-16-7-12-27(28-15-16)17(2)24-23(30-27)14-22-20-6-5-18-13-19(29)8-10-25(18,3)21(20)9-11-26(22,24)4/h16-24,28-29H,5-15H2,1-4H3/t16-,17-,18-,19-,20+,21-,22-,23-,24-,25-,26-,27-/m0/s1 |
InChI Key | XYNPYHXGMWJBLV-VXPJTDKGSA-N |
Popularity | 478 references in papers |
Molecular Formula | C27H45NO2 |
Molecular Weight | 415.70 g/mol |
Exact Mass | 415.345029678 g/mol |
Topological Polar Surface Area (TPSA) | 41.50 Ų |
XlogP | 6.20 |
Atomic LogP (AlogP) | 5.37 |
H-Bond Acceptor | 3 |
H-Bond Donor | 2 |
Rotatable Bonds | 0 |
77-59-8 |
Tomatidin |
5alpha-Tomatidan-3beta-ol |
(3beta,5alpha,22beta,25S)-Spirosolan-3-ol |
CHEBI:9629 |
(22S,25S)-5alpha-spirosolan-3beta-ol |
2B73S48786 |
SMR001233234 |
EINECS 201-040-3 |
NSC 27592 |
There are more than 10 synonyms. If you wish to see them all click here. |

Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9904 | 99.04% |
Caco-2 | - | 0.5625 | 56.25% |
Blood Brain Barrier | + | 0.7879 | 78.79% |
Human oral bioavailability | - | 0.5000 | 50.00% |
Subcellular localzation | Lysosomes | 0.5355 | 53.55% |
OATP2B1 inhibitior | - | 0.5716 | 57.16% |
OATP1B1 inhibitior | + | 0.9005 | 90.05% |
OATP1B3 inhibitior | + | 0.9376 | 93.76% |
MATE1 inhibitior | - | 0.9400 | 94.00% |
OCT2 inhibitior | - | 0.5500 | 55.00% |
BSEP inhibitior | - | 0.4922 | 49.22% |
P-glycoprotein inhibitior | - | 0.6134 | 61.34% |
P-glycoprotein substrate | - | 0.5949 | 59.49% |
CYP3A4 substrate | + | 0.7144 | 71.44% |
CYP2C9 substrate | - | 0.7859 | 78.59% |
CYP2D6 substrate | - | 0.7002 | 70.02% |
CYP3A4 inhibition | - | 0.9681 | 96.81% |
CYP2C9 inhibition | - | 0.9071 | 90.71% |
CYP2C19 inhibition | - | 0.9025 | 90.25% |
CYP2D6 inhibition | - | 0.9231 | 92.31% |
CYP1A2 inhibition | - | 0.9354 | 93.54% |
CYP2C8 inhibition | - | 0.6302 | 63.02% |
CYP inhibitory promiscuity | - | 0.9450 | 94.50% |
UGT catelyzed | + | 1.0000 | 100.00% |
Carcinogenicity (binary) | - | 1.0000 | 100.00% |
Carcinogenicity (trinary) | Non-required | 0.5808 | 58.08% |
Eye corrosion | - | 0.9867 | 98.67% |
Eye irritation | - | 0.9463 | 94.63% |
Skin irritation | - | 0.7721 | 77.21% |
Skin corrosion | - | 0.8912 | 89.12% |
Ames mutagenesis | - | 0.7454 | 74.54% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.4544 | 45.44% |
Micronuclear | - | 0.6400 | 64.00% |
Hepatotoxicity | - | 0.7313 | 73.13% |
skin sensitisation | - | 0.8311 | 83.11% |
Respiratory toxicity | + | 0.7556 | 75.56% |
Reproductive toxicity | + | 0.8667 | 86.67% |
Mitochondrial toxicity | + | 0.7250 | 72.50% |
Nephrotoxicity | - | 0.7062 | 70.62% |
Acute Oral Toxicity (c) | III | 0.7096 | 70.96% |
Estrogen receptor binding | + | 0.7039 | 70.39% |
Androgen receptor binding | - | 0.8512 | 85.12% |
Thyroid receptor binding | + | 0.6964 | 69.64% |
Glucocorticoid receptor binding | + | 0.7683 | 76.83% |
Aromatase binding | + | 0.7302 | 73.02% |
PPAR gamma | + | 0.5858 | 58.58% |
Honey bee toxicity | - | 0.6871 | 68.71% |
Biodegradation | - | 0.6500 | 65.00% |
Crustacea aquatic toxicity | + | 0.5700 | 57.00% |
Fish aquatic toxicity | - | 0.8175 | 81.75% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL4931 | Q15125 | 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase |
583 nM |
Ki |
via Super-PRED
|
CHEMBL3577 | P00352 | Aldehyde dehydrogenase 1A1 |
398.1 nM |
Potency |
via Super-PRED
|
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 96.00% | 96.09% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 95.76% | 97.09% |
CHEMBL204 | P00734 | Thrombin | 95.10% | 96.01% |
CHEMBL4681 | P42330 | Aldo-keto-reductase family 1 member C3 | 92.89% | 89.05% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 90.66% | 91.11% |
CHEMBL1163125 | O60885 | Bromodomain-containing protein 4 | 90.21% | 97.31% |
CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 89.91% | 95.58% |
CHEMBL238 | Q01959 | Dopamine transporter | 89.38% | 95.88% |
CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 89.30% | 97.25% |
CHEMBL1994 | P08235 | Mineralocorticoid receptor | 89.01% | 100.00% |
CHEMBL233 | P35372 | Mu opioid receptor | 87.50% | 97.93% |
CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 87.21% | 92.88% |
CHEMBL241 | Q14432 | Phosphodiesterase 3A | 86.79% | 92.94% |
CHEMBL3045 | P05771 | Protein kinase C beta | 86.15% | 97.63% |
CHEMBL1871 | P10275 | Androgen Receptor | 85.95% | 96.43% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 85.74% | 94.45% |
CHEMBL237 | P41145 | Kappa opioid receptor | 85.04% | 98.10% |
CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 85.03% | 96.38% |
CHEMBL1907601 | P11802 | Cyclin-dependent kinase 4/cyclin D1 | 84.75% | 98.99% |
CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 84.02% | 91.03% |
CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 82.93% | 96.61% |
CHEMBL4523377 | Q86WV6 | Stimulator of interferon genes protein | 82.57% | 95.48% |
CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 82.53% | 96.95% |
CHEMBL2996 | Q05655 | Protein kinase C delta | 81.79% | 97.79% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 81.34% | 95.89% |
CHEMBL4581 | P52732 | Kinesin-like protein 1 | 80.95% | 93.18% |
CHEMBL3922 | P50579 | Methionine aminopeptidase 2 | 80.80% | 97.28% |
CHEMBL3351 | Q13085 | Acetyl-CoA carboxylase 1 | 80.77% | 93.04% |
CHEMBL4482 | O96013 | Serine/threonine-protein kinase PAK 4 | 80.65% | 95.42% |
CHEMBL221 | P23219 | Cyclooxygenase-1 | 80.10% | 90.17% |
CHEMBL242 | Q92731 | Estrogen receptor beta | 80.03% | 98.35% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Solanum aculeastrum |
Solanum demissum |
Solanum donianum |
Solanum dunalianum |
Solanum lycopersicum |
Solanum neocardenasii |
Solanum polyadenium |
Solanum tuberosum |
PubChem | 65576 |
LOTUS | LTS0230436 |
wikiData | Q27108452 |